Note 9 — Earnings Per Share

Earnings per share (“EPS”) is calculated on both a basic and a diluted basis. Basic EPS excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, or resulted from the issuance of common stock that then shared in earnings. Both basic and diluted EPS exclude common shares in treasury. For diluted EPS, the weighted-average number of common shares outstanding was diluted only by unvested performance stock units (“PSUs”) under the treasury method for the three month periods ended March 31, 2026 and 2025.

Unvested restricted stock awards contain rights to non-forfeitable dividends and are therefore considered participating securities prior to vesting. As a result, they have been included in the earnings allocation in computing basic and diluted EPS under the two-class method.

The following table is a reconciliation of the components used to derive basic and diluted EPS for the periods indicated:


	Three Months Ended March 31,
	2026		2025
	(dollars in thousands, except per share and unit amounts)
Basic EPS
Net income	$	22,557	$	17,672
Less: income allocated to unvested restricted stock		181		148
Income allocated to common shares	$	22,376	$	17,524
Weighted-average shares for basic EPS		29,629,130		29,937,660
Basic EPS (1)	$	0.76	$	0.59

Effect of dilutive PSUs		179,869		120,588

Diluted EPS
Income allocated to common shares	$	22,376	$	17,524
Weighted-average shares for diluted EPS		29,808,999		30,058,248
Diluted EPS (1)	$	0.75	$	0.58

(1)

Per share amounts may not be able to be recalculated using net income and weighted-average shares presented above due to rounding.

There were no options outstanding during the three months ended March 31, 2026. On a weighted-average basis, options to purchase 3,000 shares of common stock were excluded from the calculation of diluted earnings per share for the three months ended March 31, 2025 because their effect would have been anti-dilutive. Options with an exercise price greater than the average market price of the common shares are considered anti-dilutive. There were no anti-dilutive unvested PSUs outstanding for the three months ended March 31, 2026 or 2025.

During the three months ended March 31, 2026, 57,754 PSUs were awarded to executive officers from the 2021 Equity Compensation Plan, with a fair value of $1.5 million on the grant date of March 13, 2026. These units have a three-year cliff vesting period and include dividend equivalent rights. During the three months ended March 31, 2025, 52,526 PSUs were awarded to executive officers from the 2021 Equity Compensation Plan, with a fair value of $1.2 million on the grant date of March 26, 2025. These units also have a three-year cliff vesting period and include dividend equivalent rights. Total PSUs outstanding as of March 31, 2026 were 197,417 with an aggregate grant fair value of $3.8 million. Total PSUs outstanding as of March 31, 2025 were 194,820 with an aggregate grant fair value of $3.6 million.